Abivax SA American Depositary Shares

Stock Chart, Company Information, and Scan Results

$126.14(as of Apr 10, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators

Stock Price$126.14
Ticker SymbolABVX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees69
CountyUSA
Market Cap$10,269.6M
EBIDTA-245.0M
10-Day Moving Average115.54
P/E Ratio-16.59
20-Day Moving Average116.67
Forward P/E Ratio0.00
50-Day Moving Average117.83
Earnings per Share-5.63
200-Day Moving Average94.97
Profit Margin11,009.07%
RSI60.08
Shares Outstanding79.3M
ATR6.06
52-Week High148.83
Volume998,400
52-Week Low5.59
Most Recent Support Level113.75
Book Value455.0M
Most Recent Resistance Level120.00
P/B Ratio19.27
Upper Keltner130.31
P/S RatioInfinity
Lower Keltner103.02
Debt-to-Equity Ratio130.31
Next Earnings Date09/08/2026
Cash Surplus453.5M
Next Ex-Dividend DateUnknown

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Abivax SA American Depositary Shares In Our Stock Scanner

As of Apr 13, 2026
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.